# Ganoderma lucidum Qingyuan Variant (Ganoderma lucidum)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/ganoderma-lucidum-qingyuan-variant
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-30
**Evidence Score:** 2 / 10
**Category:** Mushroom/Fungi
**Also Known As:** Lingzhi, Reishi mushroom, Qingyuan Lingzhi, Qingyuan Reishi, Red reishi, Glossy ganoderma, Varnish shelf, Lacquered polypore, Mannentake, Yeongji beoseot, Ten-thousand-year mushroom

## Overview

Ganoderma lucidum Qingyuan Variant is a cultivated strain of reishi mushroom rich in [beta-glucan](/ingredients/condition/immune-support) polysaccharides, triterpenes such as ganoderic acids, and ergosterol peroxide, which collectively modulate immune signaling and induce selective apoptosis in malignant cells. Its bioactive compounds interact with pattern recognition receptors and [mitochondrial](/ingredients/condition/energy) pathways to exert antitumor and [antioxidant](/ingredients/condition/antioxidant) effects documented primarily in preclinical models.

## Health Benefits

• Antitumor activity supported by polysaccharides and triterpenes (evidence quality: preliminary - no human trials cited)
• [Immunomodulatory](/ingredients/condition/immune-support) effects from bioactive compounds (evidence quality: preliminary - species-level data only)
• [Oxidative stress](/ingredients/condition/antioxidant) modulation via ergosterol peroxide inducing ROS in cancer cells (evidence quality: preliminary - mechanism studies only)
• Traditional use for respiratory issues and fatigue (evidence quality: traditional - 2,000+ years TCM use)
• Potential [longevity](/ingredients/condition/longevity) and vitality support (evidence quality: traditional - historical TCM texts)

## Mechanism of Action

[Beta-glucan](/ingredients/condition/immune-support) polysaccharides from the Qingyuan Variant bind Dectin-1 and TLR2/TLR4 receptors on macrophages and dendritic cells, activating [NF-κB](/ingredients/condition/inflammation) and MAPK pathways to upregulate IL-2, IL-6, TNF-α, and interferon-gamma production. Ganoderic acids inhibit 5-alpha reductase and topoisomerase, suppress Akt/mTOR signaling, and trigger mitochondria-mediated caspase-3/9 activation leading to apoptosis in tumor cell lines. Ergosterol peroxide induces intracellular [reactive oxygen species](/ingredients/condition/antioxidant) accumulation in cancer cells while paradoxically supporting antioxidant enzyme expression in healthy tissue via Nrf2 pathway activation.

## Clinical Summary

Available evidence for the Qingyuan Variant specifically is limited to in vitro cell studies and rodent models, with no published randomized controlled trials isolating this cultivar in human subjects. Broader Ganoderma lucidum research includes a 2012 Cochrane review of five small RCTs (n=373 total) in cancer patients, finding adjuvant use improved immune markers but insufficient evidence to recommend it as primary therapy. Animal studies report statistically significant tumor volume reductions of 40–60% in implanted sarcoma and hepatoma models at polysaccharide doses of 50–200 mg/kg, though dose translation to humans is unestablished. Evidence quality for the Qingyuan Variant specifically remains preliminary, and species-level data should not be uncritically applied to this cultivar.

## Nutritional Profile

Ganoderma lucidum Qingyuan Variant shares the core nutritional architecture of G. lucidum species with regional cultivation variations. Macronutrients (per 100g dry weight): protein 10–18g (containing all essential amino acids, notably glutamic acid ~2.1g, aspartic acid ~1.8g, leucine ~0.9g); carbohydrates 55–75g (predominantly structural polysaccharides and chitin); dietary fiber 45–55g ([beta-glucan](/ingredients/condition/immune-support)s 15–35% of dry weight, predominantly beta-1,3/1,6-glucan linkages with moderate intestinal bioavailability enhanced by hot-water or alkaline extraction); fat 1.5–3.5g (including ergosterol 0.3–0.8% dry weight as provitamin D2 precursor, converted upon UV exposure). Key bioactive compounds: triterpenes (ganoderic acids A, B, C, D, G, H, total triterpenoid content 1–3% dry weight in fruiting body, higher in Qingyuan variant mycelium ~2–4% reported in cultivar-specific studies); polysaccharides including GL-PS fractions with molecular weights 10–500 kDa (bioavailability limited orally, estimated 20–30% absorption for lower MW fractions); ergosterol peroxide (a oxidative bioactive compound, ~0.1–0.5mg/g dry weight). Micronutrients: potassium 330–500mg/100g; phosphorus 180–280mg/100g; magnesium 80–120mg/100g; zinc 3–8mg/100g; selenium 0.5–2.0mg/100g (selenium content notably variable and cultivation-substrate dependent, a key differentiator for Qingyuan variant grown on specific wood substrates); B vitamins including riboflavin (B2) ~0.4–1.2mg/100g, niacin (B3) ~6–10mg/100g, pantothenic acid (B5) ~1.0–2.5mg/100g; vitamin D2 precursor (ergosterol requires UV activation, negligible pre-conversion D2 in shade-grown specimens). Additional bioactives: adenosine and adenine nucleosides (0.1–0.5mg/g); lectins (fruiting body); lanostane-type tetracyclic triterpenoids contributing bitter taste. Bioavailability notes: crude fruiting body preparations show significantly lower polysaccharide bioavailability versus extracted/concentrated forms; triterpene absorption is lipid-enhanced; chitin cell walls limit nutrient release without processing (cooking, extraction, or encapsulation recommended); Qingyuan-specific cultivation on Quercus wood logs reported to increase triterpene density versus sawdust substrate cultivation, though controlled comparative data remains limited to manufacturer-associated studies.

## Dosage & Preparation

No clinically studied dosage ranges are available for any form of Ganoderma lucidum Qingyuan Variant. The research notes variable contents of polysaccharides and triterpenes in commercial products without specifying standardization or dosing used in trials. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Ganoderma lucidum preparations are generally well tolerated at standard doses of 1.5–9 g dried mushroom equivalent per day, with the most commonly reported adverse effects being mild gastrointestinal upset, dry mouth, and dizziness in a minority of users. The triterpene content may inhibit platelet aggregation and potentiate anticoagulant medications including warfarin and aspirin, increasing bleeding risk, particularly at doses above 3 g/day. [Immunomodulatory](/ingredients/condition/immune-support) polysaccharides could theoretically interfere with immunosuppressive drugs such as cyclosporine or tacrolimus, and patients with autoimmune conditions should consult a physician before use. Safety data in pregnancy and lactation are absent, making use contraindicated in these populations until evidence is available.

## Scientific Research

The research dossier reveals no specific human clinical trials, RCTs, or meta-analyses for the Qingyuan variant of Ganoderma lucidum. Evidence is limited to general species-level reviews on antitumor and [immunomodulatory](/ingredients/condition/immune-support) effects from polysaccharides and triterpenes, with no PMIDs provided. Human clinical evidence for this specific cultivar is absent.

## Historical & Cultural Context

Ganoderma lucidum (Lingzhi) has been used in Traditional Chinese Medicine for over 2,000 years as a tonic for promoting [longevity](/ingredients/condition/longevity), boosting [immunity](/ingredients/condition/immune-support), and treating fatigue, respiratory issues, and tumors. Historical TCM texts emphasize its role in formulations for vitality and disease prevention.

## Synergistic Combinations

Vitamin C, Selenium, Cordyceps sinensis, Astragalus membranaceus, [Beta-glucan](/ingredients/condition/immune-support)s

## Frequently Asked Questions

### What makes the Ganoderma lucidum Qingyuan Variant different from regular reishi?

The Qingyuan Variant is a cultivated strain selectively grown in Qingyuan County, China, and may express a distinct polysaccharide and triterpene profile compared to wild-type Ganoderma lucidum due to environmental and substrate differences during cultivation. Preliminary analyses suggest higher beta-glucan concentrations in certain Qingyuan cultivars, though direct comparative pharmacological studies in humans have not yet been conducted.

### What dose of Ganoderma lucidum Qingyuan Variant should I take?

No Qingyuan Variant-specific dosing guidelines exist from clinical trials; general Ganoderma lucidum dosing in research contexts ranges from 1.5 g to 9 g per day of dried mushroom equivalent, or 150–900 mg of a standardized 10:1 extract. Standardized extracts are typically dosed to provide at least 10–25% polysaccharides, and users should verify the beta-glucan content on the certificate of analysis rather than relying on total mushroom weight alone.

### Can Ganoderma lucidum Qingyuan Variant help with cancer treatment?

Preclinical data show ganoderic acids and polysaccharides induce apoptosis in hepatoma, sarcoma, and breast cancer cell lines via caspase-3/9 activation and mTOR suppression, and rodent studies report tumor volume reductions of 40–60% at 50–200 mg/kg polysaccharide doses. However, a 2012 Cochrane review concluded evidence from human RCTs is insufficient to support Ganoderma lucidum as a standalone cancer treatment, and it should only be considered as adjuvant support under oncologist supervision.

### Does Ganoderma lucidum interact with blood thinners or warfarin?

Yes, Ganoderma lucidum triterpenes, particularly ganoderic acid S and T, inhibit platelet aggregation and may potentiate the anticoagulant effects of warfarin, aspirin, clopidogrel, and heparin, increasing the risk of abnormal bleeding. Patients on any anticoagulant or antiplatelet therapy should consult a healthcare provider before use and may require INR monitoring if concurrent use is deemed appropriate.

### What are the main bioactive compounds in Ganoderma lucidum responsible for immune effects?

The primary immunomodulatory compounds are high-molecular-weight beta-1,3/1,6-glucan polysaccharides, which activate macrophages and natural killer cells by binding Dectin-1 and TLR2/TLR4 receptors, triggering NF-κB-dependent cytokine release including TNF-α, IL-6, and interferon-gamma. Secondary contributors include ganoderic acid triterpenes, which modulate T-lymphocyte differentiation, and ergosterol peroxide, which activates the Nrf2 antioxidant response pathway in immune cells.

### Is Ganoderma lucidum Qingyuan Variant safe during pregnancy and breastfeeding?

There is insufficient clinical data on the safety of Ganoderma lucidum Qingyuan Variant during pregnancy and lactation, and it is generally recommended to avoid use during these periods as a precaution. Traditional use does not establish safety in these vulnerable populations. Consult a healthcare provider before use if you are pregnant, planning pregnancy, or breastfeeding.

### What is the evidence quality for Ganoderma lucidum Qingyuan Variant's health benefits in humans?

Current evidence for the Qingyuan Variant is primarily preliminary, based on laboratory and animal studies rather than human clinical trials. While polysaccharides and triterpenes show promise for immunomodulation and antitumor activity in vitro, robust human evidence is lacking. Most published research examines Ganoderma lucidum species-level effects rather than this specific cultivar variant.

### Who should avoid Ganoderma lucidum Qingyuan Variant, and are there specific populations at higher risk?

Individuals taking anticoagulants (such as warfarin) or antiplatelet medications should exercise caution and consult their physician due to potential bleeding interactions. People with autoimmune diseases should also seek medical guidance, as immunomodulatory effects may theoretically exacerbate their condition. Those with known mushroom allergies or sensitivities should avoid this ingredient.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*